Lung Transplant READY CF 2: A Multi-site RCT
Cystic Fibrosis
About this trial
This is an interventional other trial for Cystic Fibrosis focused on measuring Cystic Fibrosis, Lung Transplantation, Advanced Lung Disease, Decision Support Tool
Eligibility Criteria
Inclusion Criteria: Diagnosis of cystic fibrosis FEV1 less than 50% of predicted Exclusion Criteria: People who are unable to provide informed consent People who are lung transplant recipients Unable to read or understand English or Spanish to complete surveys or access the website (currently only available in English and Spanish)
Sites / Locations
- University of California at Los Angeles (UCLA)
- National Jewish Health
- Yale University
- University of Kansas
- Maine Health
- University of Minnesota
- University of Cincinnati
- University of Pittsburgh
- University of Washington Medical Center - MontlakeRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention
Attention-control
Access to an investigator-designed web-based educational resource with information about lung transplant for three months.
Access to a publicly available web-based educational resource with information about transplant for three months.